Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Prospect Capital Corporation (PSEC) Price & Performance

Dolby Laboratories, Inc.Trade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Prospect Capital Corporation — how do they compare? Dolby Laboratories, Inc. trades at $58.74 (market cap $5.47B), while Prospect Capital Corporation trades at $1.72 (market cap $974.22M). The key difference: Dolby Laboratories, Inc. is far larger — about 5.6× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.01%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Prospect Capital Corporation for 78 Days on average.

DLBPSEC
Market Cap
$5.47B$974.22M
Volume
1,058,2845,779,996
Sector
TechnologyFinancials
52-Week High
$70.09$3.05
52-Week Low
$48.51$1.82
Typical Hold Time
98 Days78 Days
Enterprise Value
$4.85B$2.73B
Dividend Yield
2.46%23.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

DLB trades at $58.74, up 0.67% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue has been stable around $1.3B, with a net income margin of 18.9% in 2025. Recent news highlights expansion of Dolby Atmos and Vision with Meta and a leadership transition to Marc Whitten.

The outlook is mixed, with a consensus analyst price target of $90.33 suggesting significant upside, but technical indicators and a projected net cash flow decline in 2026 pose risks. Investment opportunities lie in the company's high gross margins and strategic partnerships, while risks include execution challenges and market volatility.

Prospect Capital Corporation

PSEC trades at $1.82, down 1.09% today, with a bearish technical outlook from moving averages. The company shows mixed fundamentals with a low P/B of 0.33 but concerning revenue volatility, including a -$407M revenue in 2025. Recent quarterly EPS has consistently beaten expectations, and the company maintains regular dividend distributions. Analyst sentiment is cautious with 55% hold ratings, while technical indicators show oversold conditions with RSI below 10.

PSEC presents a high-risk opportunity with a discounted valuation and strong dividend yield, but faces significant challenges from volatile revenue performance and negative cash flow. The stock's current technical weakness and mixed analyst consensus suggest cautious approach required despite attractive yield characteristics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

PSEC
95% Buy5% Sell
Avg holding period · 78 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC →